Skip to main content
. Author manuscript; available in PMC: 2021 Mar 5.
Published in final edited form as: Curr Opin Rheumatol. 2021 Mar 1;33(2):155–162. doi: 10.1097/BOR.0000000000000776

Table 2.

Autoantibodies detected in patients with COVID-19

Autoantibodies Clinical significance Refs
ANA Poor prognosis and a significant higher respiratory rate. [14]
APL Poor prognosis and a significant higher respiratory rate.
Possible association with a hyperinflammatory state and thrombosis and thromboembolism.
[14,51]
Lupus anticoagulant A higher rate of thrombosis [50]
Cold agglutinins Hemolytic anemia.
Complicating laboratory assessment and renal replacement therapy.
[54,57]
Anti-Ro/SSA antibodies Possible association with severe pneumonia. [55]
anti-Caspr2 antibody Unclear. [53]
anti- GD1b antibody Unclear. [53]
Anti-MOG antibody Unclear. [52]
Red cell –bound antibodies Associated with the severity of anemia. [56]